The Effect of Silencing Fatty Acid Elongase 4 and 6 Genes on the Proliferation and Migration of Colorectal Cancer Cells

被引：2
作者：
Czumaj, Aleksandra [1 ]
Kobiela, Jaroslaw [2 ,3 ]
Mika, Adriana [1 ]
Pappou, Emmanouil [4 ]
Sledzinski, Tomasz [1 ]
机构：
[1] Med Univ Gdansk, Fac Pharm, Dept Pharmaceut Biochem, PL-80211 Gdansk, Poland
[2] Med Univ Gdansk, Fac Med, Dept Gen Endocrine & Transplant Surg, PL-80211 Gdansk, Poland
[3] Med Univ Gdansk, Fac Med, Dept Surg Oncol, Gdansk, Poland
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 24期
关键词：
colorectal cancer; lipid metabolism; fatty acid elongation; siRNA; cell proliferation; cell migration; INHIBITOR; MICRORNAS; DISCOVERY; PATHWAYS; ROLES;
D O I：
10.3390/ijms242417615
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Colorectal cancer (CRC) cells show some alterations in lipid metabolism, including an increased fatty acid elongation. This study was focused on investigating the effect of a small interfering RNA (siRNA)-mediated decrease in fatty acid elongation on CRC cells' survival and migration. In our study, the elongase 4 (ELOVL4) and elongase 6 (ELOVL6) genes were observed to be highly overexpressed in both the CRC tissue obtained from patients and the CRC cells cultured in vitro (HT-29 and WiDr cell lines). The use of the siRNAs for ELOVL4 and ELOVL6 reduced cancer cell proliferation and migration rates. These findings indicate that the altered elongation process decreased the survival of CRC cells, and in the future, fatty acid elongases can be potentially good targets in novel CRC therapy.
引用
收藏
页数：10
相关论文
共 45 条
  • [1] Epigenetic and genetic features of 24 colon cancer cell lines
    Ahmed, D.
    Eide, P. W.
    Eilertsen, I. A.
    Danielsen, S. A.
    Eknaes, M.
    Hektoen, M.
    Lind, G. E.
    Lothe, R. A.
    [J]. ONCOGENESIS, 2013, 2 : e71 - e71
  • [2] Colon Cancer: A Clinician's Perspective in 2019
    Ahmed, Monjur
    [J]. GASTROENTEROLOGY RESEARCH, 2020, 13 (01) : 1 - 10
  • [3] Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
    Berg, Kaja C. G.
    Eide, Peter W.
    Eilertsen, Ina A.
    Johannessen, Bjarne
    Bruun, Jarle
    Danielsen, Stine A.
    Bjornslett, Merete
    Meza-Zepeda, Leonardo A.
    Eknaes, Mette
    Lind, Guro E.
    Myklebost, Ola
    Skotheim, Rolf I.
    Sveen, Anita
    Lothe, Ragnhild A.
    [J]. MOLECULAR CANCER, 2017, 16
  • [4] Cancer Focus Lipid metabolism and cancer
    Bian, Xueli
    Liu, Rui
    Meng, Ying
    Xing, Dongming
    Xu, Daqian
    Lu, Zhimin
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (01)
  • [5] Bond LM., 2016, Biochemistry of Lipids, Lipoproteins and Membranes, P185
  • [6] ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer
    Centenera, Margaret M.
    Scott, Julia S.
    Machiels, Jelle
    Nassar, Zeyad D.
    Miller, Deanna C.
    Zinonos, Irene
    Dehairs, Jonas
    Burvenich, Ingrid J. G.
    Zadra, Giorgia
    Chetta, Paolo M.
    Bango, Clyde
    Evergren, Emma
    Ryan, Natalie K.
    Gillis, Joanna L.
    Mah, Chui Yan
    Tieu, Terence
    Hanson, Adrienne R.
    Carelli, Ryan
    Bloch, Katarzyna
    Panagopoulos, Vasilios
    Waelkens, Etienne
    Derua, Rita
    Williams, Elizabeth D.
    Evdokiou, Andreas
    Cifuentes-Rius, Anna
    Voelcker, Nicolas H.
    Mills, Ian G.
    Tilley, Wayne D.
    Scott, Andrew M.
    Loda, Massimo
    Selth, Luke A.
    Swinnen, Johannes, V
    Butler, Lisa M.
    [J]. CANCER RESEARCH, 2021, 81 (07) : 1704 - 1718
  • [7] Small interfering RNA for cancer treatment: overcoming hurdles in delivery
    Charbe, Nitin Bharat
    Amnerkar, Nikhil D.
    Ramesh, B.
    Tambuwala, Murtaza M.
    Bakshi, Hamid A.
    Aljabali, Alaa A. A.
    Khadse, Saurabh C.
    Satheeshkumar, Rajendran
    Satija, Saurabh
    Metha, Meenu
    Chellappan, Dinesh Kumar
    Shrivastava, Garima
    Gupta, Gaurav
    Negi, Poonam
    Dua, Kamal
    Zacconi, Flavia C.
    [J]. ACTA PHARMACEUTICA SINICA B, 2020, 10 (11) : 2075 - 2109
  • [8] Interfering with disease: a progress report on siRNA-based therapeutics
    de Fougerolles, Antonin
    Vornlocher, Hans-Peter
    Maraganore, John
    Lieberman, Judy
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (06) : 443 - 453
  • [9] Novel Cellular Functions of Very Long Chain-Fatty Acids: Insight From ELOVL4 Mutations
    Deak, Ferenc
    Anderson, Robert E.
    Fessler, Jennifer L.
    Sherry, David M.
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [10] G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
    Faul, Franz
    Erdfelder, Edgar
    Lang, Albert-Georg
    Buchner, Axel
    [J]. BEHAVIOR RESEARCH METHODS, 2007, 39 (02) : 175 - 191
12345